In This Section

AACR Special Conference: Precision Prevention, Early Detection, and Interception of Cancer

The American Association for Cancer Research (AACR) has made the difficult decision, after careful consideration and a comprehensive evaluation of currently available information related to the continuing situation with novel coronavirus (COVID-19) and the Omicron variant outbreak, to postpone the Precision Prevention, Early Detection, and Interception of Cancer Special Conference originally scheduled for January 21-23, 2022, in Austin, Texas. Please note that this postponement applies to this conference and does not apply to other planned AACR events.

We recognize that the new data, exchange of information, and opportunities for collaboration offered by this conference are highly valued by the cancer research community, and we are working to reschedule the conference as soon as possible. Information on the rescheduled program will be sent by email and posted on www.aacr.org once it is available.

  • If you submitted an abstract, please be advised that the abstracts that were submitted to the conference will not be published as originally scheduled.  We encourage authors to submit an updated abstract once submission opens for the new conference dates.  If you have any questions, please email [email protected].
  • If you registered for the conference, the AACR will issue a refund in the manner in which it was received. If you have any questions, please contact [email protected].
  • If you have a room reservation at Hyatt Regency Austin, your cancellation will be accepted at no charge up to 48 hours in advance of your scheduled check-in date; please contact the hotel at (512) 477-1234 to cancel your reservation as soon as possible.
  • If you booked a flight to Austin, many airlines have adjusted their rebooking and cancellation policies in response to the COVID-19 crisis. Please contact your airline or booking agent directly to cancel your travel to Austin. 

The AACR deeply appreciates your patience and understanding. Please look for emails in the coming weeks as we work to reschedule this program as soon as possible. If you have any questions, please email [email protected]

Our heartfelt sympathies go out to everyone who has been impacted by this global health crisis.

CONFERENCE CHAIR

Timothy Rebbeck, Dana Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

conference cochairs

Sangeeta Bhatia, Massachusetts Institute of Technology, Cambridge, Massachusetts
Luis Alberto Diaz, Jr., Memorial Sloan-Kettering Cancer Center, New York, New York
Ernest T. Hawk, The University of Texas MD Anderson Cancer Center, Houston, Texas
Philip Kantoff, Convergent Therapeutics, Cambridge, Massachusetts

Lead supporter

AbbVie


#AACRprev22